Literature DB >> 31132801

The psychological impact of being on a monitoring pathway for localised prostate cancer: A UK-wide mixed methods study.

Lauren Matheson1, Sarah Wilding2, Richard Wagland3, Johana Nayoan3, Carol Rivas3, Amy Downing2, Penny Wright2, Jo Brett1, Therese Kearney4, William Cross5, Adam Glaser2,3, Anna Gavin5, Eila Watson1.   

Abstract

OBJECTIVE: To address concerns over the psychological impact of being on a monitoring pathway following prostate cancer (PCa) diagnosis, this study compared the psychological status of men on active surveillance (AS) or watchful waiting (WW) with men on active treatment (AT) and explored psychological adjustment in men on AS/WW.
METHODS: Cross-sectional survey of UK men diagnosed with PCa 18 to 42 months previously (n = 16 726, localised disease at diagnosis) and telephone interviews with 24 men on AS/WW. Psychological outcomes were measured using two validated scales (Short Warwick-Edinburgh Mental Well-being Scale [SWEMWBS] and Kessler Psychological Distress Scale). Univariable and multivariable analyses compared outcomes between men on AS/WW and AT. Thematic analysis of interviews was undertaken, informed by a previously developed theory of adjustment to cancer.
RESULTS: A total of 3986 (23.8%) respondents were on AS/WW. Overall, psychological outcomes were similar or better in men on AS/WW compared with those receiving AT (SWEMWBS: Poor well-being; 12.3% AS/WW vs 13.9% AT, adjusted OR = 0.86, 95% CI, 0.76-0.97; K6: severe psychological distress; 4.6% vs 5.4%, adjusted OR = 0.90, 95% CI, 0.74-1.08). Interviews indicated that most men on AS/WW had adjusted positively. Men with poorer well-being were less able to accept, reframe positively and normalise their diagnosis, described receiving insufficient information and support, and reported a lack of confidence in their health care professionals.
CONCLUSIONS: Most men on AS/WW cope well psychologically. Men making treatment decisions should be given this information. Psychological health should be assessed to determine suitability for AS/WW, and at monitoring appointments. A clear action plan and support from health care professionals is important.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LAPCD; active surveillance; cancer; mixed methods; monitoring; oncology; prostate cancer; psychological well-being; watchful waiting

Mesh:

Year:  2019        PMID: 31132801     DOI: 10.1002/pon.5133

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  3 in total

Review 1.  Supportive care needs of men with prostate cancer: A systematic review update.

Authors:  Jai Prashar; Patricia Schartau; Elizabeth Murray
Journal:  Eur J Cancer Care (Engl)       Date:  2022-01-17       Impact factor: 2.328

2.  Why men with a low-risk prostate cancer select and stay on active surveillance: A qualitative study.

Authors:  Aaron T Seaman; Kathryn L Taylor; Kimberly Davis; Kenneth G Nepple; John H Lynch; Anthony D Oberle; Ingrid J Hall; Robert J Volk; Heather Schacht Reisinger; Richard M Hoffman
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

3.  Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial.

Authors:  Julia Wade; Jenny Donovan; Athene Lane; Michael Davis; Eleanor Walsh; David Neal; Emma Turner; Richard Martin; Chris Metcalfe; Tim Peters; Freddie Hamdy; Roger Kockelbergh; James Catto; Alan Paul; Peter Holding; Derek Rosario; Howard Kynaston; Edward Rowe; Owen Hughes; Prasad Bollina; David Gillatt; Alan Doherty; Vincent J Gnanapragasam; Edgar Paez
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.